350 related articles for article (PubMed ID: 34606847)
21. Oral administration of RDP58 ameliorated DSS-induced colitis in intestinal microbiota dependent manner.
Zheng D; Ke X; Cai H; Yan C; Chen Y; Sun J; Chen G
Int Immunopharmacol; 2024 Jul; 136():112325. PubMed ID: 38820960
[TBL] [Abstract][Full Text] [Related]
22. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.
Sefik E; Geva-Zatorsky N; Oh S; Konnikova L; Zemmour D; McGuire AM; Burzyn D; Ortiz-Lopez A; Lobera M; Yang J; Ghosh S; Earl A; Snapper SB; Jupp R; Kasper D; Mathis D; Benoist C
Science; 2015 Aug; 349(6251):993-7. PubMed ID: 26272906
[TBL] [Abstract][Full Text] [Related]
23. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.
Sham HP; Bazett M; Bosiljcic M; Yang H; Luk B; Law HT; Morampudi V; Yu HB; Pankovich J; Sutcliffe S; Bressler B; Marshall JK; Fedorak RN; Chen J; Jones M; Gunn H; Kalyan S; Vallance BA
Front Immunol; 2018; 9():2211. PubMed ID: 30319652
[No Abstract] [Full Text] [Related]
24. Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated fecal microbiota transfer in murine colitis.
Spalinger MR; Schwarzfischer M; Hering L; Shawki A; Sayoc A; Santos A; Gottier C; Lang S; Bäbler K; Geirnaert A; Lacroix C; Leventhal GE; Dai X; Rawlings D; Chan AA; Rogler G; McCole DF; Scharl M
Mucosal Immunol; 2019 Nov; 12(6):1336-1347. PubMed ID: 31501515
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
Guo XY; Liu XJ; Hao JY
J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
[TBL] [Abstract][Full Text] [Related]
26. Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model.
Natividad JM; Pinto-Sanchez MI; Galipeau HJ; Jury J; Jordana M; Reinisch W; Collins SM; Bercik P; Surette MG; Allen-Vercoe E; Verdu EF
Inflamm Bowel Dis; 2015 Aug; 21(8):1883-93. PubMed ID: 26060932
[TBL] [Abstract][Full Text] [Related]
27. Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
Gogokhia L; Buhrke K; Bell R; Hoffman B; Brown DG; Hanke-Gogokhia C; Ajami NJ; Wong MC; Ghazaryan A; Valentine JF; Porter N; Martens E; O'Connell R; Jacob V; Scherl E; Crawford C; Stephens WZ; Casjens SR; Longman RS; Round JL
Cell Host Microbe; 2019 Feb; 25(2):285-299.e8. PubMed ID: 30763538
[TBL] [Abstract][Full Text] [Related]
28. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis.
Yang Y; Zheng X; Wang Y; Tan X; Zou H; Feng S; Zhang H; Zhang Z; He J; Cui B; Zhang X; Wu Z; Dong M; Cheng W; Tao S; Wei H
Front Immunol; 2022; 13():836542. PubMed ID: 35237276
[TBL] [Abstract][Full Text] [Related]
29. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.
Seishima J; Iida N; Kitamura K; Yutani M; Wang Z; Seki A; Yamashita T; Sakai Y; Honda M; Yamashita T; Kagaya T; Shirota Y; Fujinaga Y; Mizukoshi E; Kaneko S
Genome Biol; 2019 Nov; 20(1):252. PubMed ID: 31767028
[TBL] [Abstract][Full Text] [Related]
30. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
[TBL] [Abstract][Full Text] [Related]
31. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
Shi G; Kong J; Wang Y; Xuan Z; Xu F
J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D Regulates the Microbiota to Control the Numbers of RORγt/FoxP3+ Regulatory T Cells in the Colon.
Cantorna MT; Lin YD; Arora J; Bora S; Tian Y; Nichols RG; Patterson AD
Front Immunol; 2019; 10():1772. PubMed ID: 31417552
[TBL] [Abstract][Full Text] [Related]
33. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
34. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
[TBL] [Abstract][Full Text] [Related]
35. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis.
Runtsch MC; Hu R; Alexander M; Wallace J; Kagele D; Petersen C; Valentine JF; Welker NC; Bronner MP; Chen X; Smith DP; Ajami NJ; Petrosino JF; Round JL; O'Connell RM
Oncotarget; 2015 Oct; 6(30):28556-72. PubMed ID: 26456940
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
38. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.
Crothers JW; Chu ND; Nguyen LTT; Phillips M; Collins C; Fortner K; Del Rio-Guerra R; Lavoie B; Callas P; Velez M; Cohn A; Elliott RJ; Wong WF; Vo E; Wilcox R; Smith M; Kassam Z; Budd R; Alm EJ; Mawe GM; Moses PL
BMC Gastroenterol; 2021 Jul; 21(1):281. PubMed ID: 34238227
[TBL] [Abstract][Full Text] [Related]
39. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.
Ohnmacht C; Park JH; Cording S; Wing JB; Atarashi K; Obata Y; Gaboriau-Routhiau V; Marques R; Dulauroy S; Fedoseeva M; Busslinger M; Cerf-Bensussan N; Boneca IG; Voehringer D; Hase K; Honda K; Sakaguchi S; Eberl G
Science; 2015 Aug; 349(6251):989-93. PubMed ID: 26160380
[TBL] [Abstract][Full Text] [Related]
40. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
